Registry for Calcium Release Deficiency Syndrome
Official title: International Calcium Release Deficiency Syndrome Registry
Run by Population Health Research Institute · NCT06508164 · Data updated 2026-11-12
This study is trying to gather information about Calcium Release Deficiency Syndrome to better understand it and find the best ways to treat people with this heart condition caused by RYR2 gene changes.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Population Health Research Institute Academic / other |
| Locations | 22 sites (San Francisco, California and 21 other locations) |
| Status | Recruiting |
| Started | November 21, 2024 |
| Main results expected | December 31, 2050 |
| Study ends | December 31, 2050 |
| Registry record updated | September 28, 2026 |
| Trial ID | NCT06508164 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with confirmed loss-of-function RYR2 variants or truncating variants associated with Calcium Release Deficiency Syndrome.
✕Probably not a fit
Patients whose RYR2 variants do not impact function may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The International CRDS Registry aims to gather extensive data on Calcium Release Deficiency Syndrome (CRDS), a genetic arrhythmia syndrome linked to life-threatening heart rhythm issues due to RYR2 gene mutations. This observational registry will evaluate the phenotypic spectrum of CRDS, assess risk stratification methods, and explore optimal treatment strategies. Patients with confirmed loss-of-function RYR2 variants will be enrolled, while those with non-functional variants will be placed in a control group. The goal is to enhance understanding and management of CRDS for affected individuals and their families.
Why it matters
Potential benefit: If successful, this registry could lead to improved management and treatment strategies for patients with Calcium Release Deficiency Syndrome.
How similar studies have gone: While CRDS is a newly identified condition, similar registries for genetic arrhythmias have shown promise in advancing understanding and treatment.
Who can join: the full rules
Show full inclusion / exclusion criteria
CRDS Cohort Inclusion Criterion: \- Presence of a rare\* RYR2 variant that is characterized to be loss-of-function based on in vitro testing# RYR2 Truncating and Large CNV Cohort Inclusion Criterion: \- Presence of a rare\* RYR2 truncating variant and/or large copy number variant involving the RYR2 gene. Carriers of a Non-Functional RYR2 variant Inclusion Criterion: \- Presence of a rare\* RYR2 variant that is characterized to be neither loss- nor gain-of-function based on in vitro testing# \*rare defined as gnomAD prevalence \< 0.1% #RYR2 in vitro functional testing will be performed in the laboratory of Dr. Wayne Chen (University of Calgary)
Where it's running
-
University of California
San Francisco, California, United States Recruiting -
Mayo Clinic
Rochester, Minnesota, United States Recruiting -
Duke University
Durham, North Carolina, United States Recruiting -
Inova Health Care Services
Fairfax, Virginia, United States Recruiting -
Garvan Institute of Medical Research
Darlinghurst, New South Wales, Australia Recruiting -
Antwerp University Hospital
Edegem, Antwerp, Belgium Recruiting
Show 16 more locations
-
Universitair Ziekenhuis Brussel
Brussels, Belgium Recruiting -
University of Calgary
Calgary, Alberta, Canada Recruiting -
Alberta Health Services
Edmonton, Alberta, Canada Recruiting -
Children's & Women's Health Centre of British Columbia
Vancouver, British Columbia, Canada Recruiting -
The University of British Columbia
Vancouver, British Columbia, Canada Recruiting -
Hamilton General Hospital
Hamilton, Ontario, Canada Recruiting -
London Health Sciences Centre - University Hospital
London, Ontario, Canada Recruiting -
Ottawa Heart Institute
Ottawa, Ontario, Canada Recruiting -
Montréal Heart Institute
Montreal, Quebec, Canada Recruiting -
Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval
Québec, Quebec, Canada Recruiting -
Rigshospitalet
Copenhagen, The Capital Region of Denmark, Denmark Recruiting -
Aarhus University Hospital
Aarhus, Denmark Recruiting -
CHU de Bordeaux
Bordeaux, New Aquitaine, France Recruiting -
Shaare Zedek Medical Center
Jerusalem, Israel Recruiting -
Oxford University Hospitals
Oxford, Oxfordshire, United Kingdom Recruiting -
City St George's, University of London
London, United Kingdom Recruiting
Study contacts
- Principal investigator: Jason D Roberts, MD MAS — McMaster University
- Study coordinator: Jason D Roberts, MD MAS
- Email: crds@phri.ca
- Phone: 905-297-3479
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Head-of-bed position after clot-removal stroke therapy
This study tests whether keeping the head of the bed flat (0 degrees) after thrombectomy improves recovery compared with a raised position in adults who had an ischemic stroke due to large vessel blockage.
-
Monitoring heart rhythm after noncardiac surgery
This study is testing if wearing a portable heart monitor for up to 14 days after noncardiac surgery can help find heart rhythm problems that are often missed, to improve care for patients.
-
Surgical procedure to prevent heart rhythm issues after cardiac surgery
This study is testing a surgical procedure to see if it can help prevent heart rhythm problems after heart surgery for patients who haven't had these issues before.
-
Using patients' own blood to reduce transfusion needs after heart surgery
This study is testing whether using patients' own blood during heart surgery can help reduce the need for blood transfusions compared to the usual method.
-
Evaluating a diagnostic test for Calcium Release Deficiency Syndrome
This study is testing a new way to diagnose Calcium Release Deficiency Syndrome by looking at how the heart responds to fast pacing, aiming to make diagnosis easier for patients with this condition and similar heart issues.
-
Short-term treatment with amiodarone for new atrial fibrillation after heart surgery
This study is testing whether a short-term treatment with amiodarone can help people who develop new atrial fibrillation after heart surgery feel better and keep their heart rhythm stable.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.